CARRIERI, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 8.748
AS - Asia 2.877
EU - Europa 2.566
SA - Sud America 678
AF - Africa 87
OC - Oceania 5
Totale 14.961
Nazione #
US - Stati Uniti d'America 8.657
SG - Singapore 1.213
CN - Cina 708
BR - Brasile 602
DE - Germania 522
SE - Svezia 403
IT - Italia 384
HK - Hong Kong 368
RU - Federazione Russa 335
VN - Vietnam 270
GB - Regno Unito 212
UA - Ucraina 167
FR - Francia 160
FI - Finlandia 120
IN - India 77
ID - Indonesia 43
CA - Canada 40
IE - Irlanda 38
CI - Costa d'Avorio 33
NL - Olanda 33
BE - Belgio 32
BD - Bangladesh 31
MX - Messico 31
TR - Turchia 30
JP - Giappone 29
PL - Polonia 27
AR - Argentina 26
AT - Austria 25
IR - Iran 22
ES - Italia 19
CH - Svizzera 17
CZ - Repubblica Ceca 16
ZA - Sudafrica 16
IQ - Iraq 15
LT - Lituania 14
EC - Ecuador 13
PK - Pakistan 11
KE - Kenya 9
CO - Colombia 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
VE - Venezuela 8
CL - Cile 7
JM - Giamaica 7
EE - Estonia 6
EG - Egitto 6
JO - Giordania 6
KR - Corea 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
AU - Australia 4
BY - Bielorussia 4
NG - Nigeria 4
NO - Norvegia 4
PY - Paraguay 4
RO - Romania 4
TH - Thailandia 4
UY - Uruguay 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
GA - Gabon 3
IL - Israele 3
MA - Marocco 3
PE - Perù 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
CR - Costa Rica 2
GE - Georgia 2
HR - Croazia 2
IS - Islanda 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AN - Antille olandesi 1
BH - Bahrain 1
CV - Capo Verde 1
ET - Etiopia 1
GI - Gibilterra 1
GN - Guinea 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MW - Malawi 1
Totale 14.954
Città #
Dallas 2.453
Fairfield 725
Singapore 617
Ashburn 607
Woodbridge 506
Chandler 505
Houston 393
Hong Kong 357
Jacksonville 354
Nyköping 298
Seattle 286
Cambridge 251
Wilmington 239
Ann Arbor 222
Beijing 175
Bari 139
Nanjing 113
Lawrence 107
Roxbury 107
Los Angeles 98
Marseille 97
New York 91
Dong Ket 84
Boardman 70
Ho Chi Minh City 68
Des Moines 64
Brooklyn 61
Munich 59
Princeton 58
Hanoi 51
Santa Clara 46
São Paulo 46
London 44
San Diego 39
Council Bluffs 36
Dublin 36
Jakarta 34
Abidjan 33
Buffalo 33
Jiaxing 32
Brussels 31
Inglewood 31
North Bergen 30
Nanchang 29
Milan 26
Chicago 25
Moscow 25
Tokyo 25
Amsterdam 24
Helsinki 23
Frankfurt am Main 22
Shenyang 22
Warsaw 22
Nuremberg 20
Rio de Janeiro 20
Tianjin 19
Redwood City 18
Denver 17
Orem 17
Chennai 16
Dearborn 16
Guangzhou 16
San Francisco 16
West Jordan 16
Changsha 15
Hebei 15
Mumbai 14
Belo Horizonte 13
Paris 13
Sannicandro di Bari 13
Atlanta 12
Boston 12
Kansas City 12
Toronto 12
Brasília 11
Leawood 11
Rome 11
San Jose 11
Shanghai 11
Johannesburg 10
Mexico City 10
Montreal 10
Phoenix 10
Redondo Beach 10
Ankara 9
Boydton 9
Curitiba 9
Düsseldorf 9
Falkenstein 9
Falls Church 9
Istanbul 9
Poplar 9
The Dalles 9
Wuhan 9
Brno 8
Goiânia 8
Juiz de Fora 8
Long Beach 8
Manchester 8
Porto Alegre 8
Totale 10.534
Nome #
1, 3‐Benzothiazoles as Antimicrobial Agents 1.085
1,3-Benzothiazoles as Antimicrobial Agents 1.072
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1 1.062
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5- fluorobenzenethiol derivatives: Design, synthesis and in vitro antimicrobial screening 195
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 194
miRNAs for the Detection of MultiDrug Resistance: Overview and Perspectives 188
Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones 181
2-Aminobenzothiazole derivatives: Search for new antifungal agents 178
Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease 165
A convenient synthesis of lubeluzole and its enantiomer: Evaluation as chemosensitizing agents on human ovarian adenocarcinoma and lung carcinoma cells 163
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 158
The chemosensitizing agent lubeluzole binds calmodulin and inhibits Ca2+/calmodulin-dependent Kinase II 148
Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects 147
Structure-property relationship study of the HPLC enantio-selective retention of neuroprotective 7-[(1-alkylpiperidin-3-yl)methoxy]coumarin derivatives on an amylose-based chiral stationary phase 147
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 142
,3-Benzothiazoles as Antimicrobial Agents 141
Effect of Methyl -β- Cyclodextrin on the antimicrobial activity of a new series of poorly water-soluble benzothiazoles 138
Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors 138
In vitro interactions between anidulafungin and nonsteroidal anti-inflammatory drugs on biofilms of Candida spp 134
New tetrahydroisoquinoline-based P-glycoprotein modulators: Decoration of the biphenyl core gives selective ligands 133
Structure-Activity Relationship Studies on Tetrahydroisoquinoline Derivatives: [4′-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-ylmethyl)biphenyl-4-ol] (MC70) Conjugated through Flexible Alkyl Chains with Furazan Moieties Gives Rise to Potent and Selective Ligands of P-glycoprotein 131
Bioisosteric Modification of To042: Synthesis and Evaluation of Promising Use-Dependent Inhibitors of Voltage-Gated Sodium Channels 131
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 129
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 128
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 126
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 126
High Affinity Central Benzodiazepine Receptor Ligands. Part 2: Quantitative Structure-Activity Relationships and Comparative Molecular Field Analysis of Pyrazolo[4,3-c]quinolin-3-ones 124
Alpidem analogues containinig a GABA or glycine moiety as new anticonvulsant agents 121
1,3,5-triazine derivatives as dual inhibitors of 5-HT6R/FAAH in search of new therapy for Alzheimer's disease 120
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 117
3D-QSAR models and docking studies of reversible inhibitors of type A and B Monoamine Oxidases 116
Structural Determinants in the Binding of BB2 Receptor Ligands: In Silico, X-Ray and NMR Studies in PD176252 Analogues. 115
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 112
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 112
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 112
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 111
Derivatives of Tenuazonic Acid as Potential New Multi-Target Anti-Alzheimer’s Disease Agents 110
Guinea-pig ileum as ex vivo model useful to characterize ligands displaying Imidazoline I2 and Adrenergic alpha2 mixed activity: a preliminary study 109
The in silico insights of α-adrenergic receptors over the last decade: methodological approaches and structural features of the 3D models 107
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 106
Understanding of the MAO-A and B Reversible Inhibitory Activity and Selectivity by Using 3D Descriptors of Lipophilicity 102
Binding Models of Reversible Inhibitors to Monoamine Oxidases 102
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 101
Alpha2-adrenoreceptors profile modulation. 3.1 (R)-(+)-m-nitrobiphenyline, a new efficient and alpha2C-subtype selective agonist 100
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 100
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 99
alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(Biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 98
Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with beta-cyclodextrins 98
High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones. 97
Evaluation of water‐soluble Mannich base prodrugs of 2,3,4,5‐tetrahydroazepino[4,3‐b]indol‐1(6H)‐one as multitarget‐directed agents for Alzheimer’s disease 97
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 96
A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE) 96
Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies. 95
Neuronal Nicotinic Agonists: a Multi-approach Development of the Pharmacophore 95
Lubeluzole: from anti-ischemic to chemosensitizing agent 95
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 94
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 93
Analisi conduttimetrica 92
Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists 91
Rational design of the new antihypertensive I1-receptor ligand 2-(2-biphenyl-2-yl-1-methyl-ethyl-)4,5-dihydro-1H-imidazole 90
High affinity central benzodiazepine receptor ligands II: QSAR studies and CoMFA analysis pyrazolo(4,3-c)quinolin-3-ones 87
Diffuse Intrinsic Pontine Glioma (DIPG): breakthrough and clinical perspective 86
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D-QSAR predictive models, 84
Binding models of reversible inhibitors to type-B monoamine oxidase 84
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 81
alfa2-adrenoreceptors profile modulation. 2.1 Biphenyline analogues as tools for selective activation of alfa2C-subtype 80
Sintesi alternativa del lubeluzolo e del suo enantiomero e valutazione come agenti in grado di potenziare l'effetto di farmaci antitumorali. 80
Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics. 80
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 78
A twenty-year journey exploring coumarin-based derivatives as bioactive molecules 77
2D- and 3D-QSAR of tocainide and mexiletine analogues acting as Na(v)1.4 channel blockers 77
Neuronal nicotinic receptor agonists: multi-approach pharmacophore development and 3D QSAR predictive models 75
Linezolid hybrid analogs: synthesis and antimicrobial studies of oxalodinone-mercaptobenzothiazole compounds 73
Recent Trends And Future Prospects In Computational GPCR Drug Discovery: From Virtual Screening To Polypharmacology. 73
Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates 72
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 71
New molecular requirements of Toc derivatives bearing a novel class of Nav1.4 blockers 71
Binding of tracizolines to the imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 71
Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets 71
null 70
Comparative Molecular Field Analysis of pyridawinone-containing alfa1-antagonists 68
Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease 68
Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils 68
Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus 67
Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases 66
null 66
Modeling the structural basis of the human CCR5 chemokine receptor functions: from homology model-builiding and molecular dynamics validation to agonist and anatgonist docking 65
SAR of Non-Nucleoside HIV-1 RT inhibitors (NNRTIs): Comparative Molecular field Analysis (CoMFA) and Docking Studies 65
Multi-approach development of a new pharmacophore for neuronal nicotinic acetylcholine receptor agonists, 65
null 65
Synthesis and Antimicrobial Activity of new-substitud-4H-1,4-benzothiazines 64
Novel Phenothiazine/Donepezil-Like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease 63
Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase 63
stant collaboration in drug discovery: The LINK3D project 62
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 61
Benzothiazole-Phthalimide Hybrids as Anti-Breast Cancer and Antimicrobial Agents 60
N‑Aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels 60
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 59
Theoretical evidence of a salt bridge disruption as the initiating process for the alpha1d-adrenergic receptor activation: a molecular dynamics and docking study 59
Extended form of a retro-inverso peptide stabilized by beta-sheet unidirectional H-bonds: Crystallographic and NMR evidence 59
Totale 13.017
Categoria #
all - tutte 56.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021783 0 0 0 0 0 61 103 70 111 180 105 153
2021/2022851 43 105 11 41 22 48 49 44 56 84 134 214
2022/20231.556 220 141 93 125 183 190 14 155 337 22 40 36
2023/2024675 44 99 26 43 52 102 40 29 39 54 52 95
2024/20252.436 73 69 196 109 66 165 221 233 148 145 356 655
2025/20265.172 698 773 2.169 677 565 290 0 0 0 0 0 0
Totale 15.343